James Thornton

Buying Time

When you’ve built three Fortune 500 companies, time becomes your most precious resource. I was 64 when my cardiologist delivered the news: without intervention, I had five to seven years remaining. I had too much left to accomplish for such a brief timeline.

Unzyme Laboratories’ VitaCore Longevity Protocol was not yet publicly available when I enrolled. As an early investor in the program, I was offered participation in the final trial phase. The decision was simple: die on schedule, or rewrite the schedule entirely.

The Procedure

The VitaCore Protocol is not a single procedure—it’s a comprehensive biological reconstruction. Over eighteen months, I underwent cellular reprogramming, organ rejuvenation, and metabolic optimization. The process was intensive, frequently painful, and occasionally terrifying when systems failed to respond as expected.

But I survived. More than survived—I was renewed.

A New Perspective

My body now functions with the efficiency of a man half my chronological age. I require less sleep, process information faster, and have energy reserves I haven’t experienced since graduate school. The stock price of my investment portfolio has never been more interesting to me.

There are social complications. Friends and colleagues my age are dying—naturally, as humans do. I attend their funerals, offer condolences to their families, and return home to my rejuvenated existence. Some have called this callous. I call it optimized resource allocation. Their mortality is no longer relevant to my planning horizon.

My wife passed three years ago, before my enhancement. I’ve since remarried—a woman thirty years my junior who appreciates my enhanced vitality. My children from my first marriage have mixed feelings about both developments.

The Long View

I’m now a consultant for Unzyme Laboratories, helping them identify other high-value individuals who might benefit from the VitaCore Protocol. The screening process is rigorous—only certain personality types adapt well to indefinite lifespan extension. Those who attach too much sentiment to traditional human lifespans find the transition… challenging.

I have no such attachments. I intend to be here for the long term. The very long term.

My current projected lifespan, based on ongoing protocol maintenance, is estimated at 180-220 years. Unzyme Laboratories has assured me that continued advancements may extend this further. I am their longest-term investor, in every sense.